User profiles for C M Dayan

Colin Dayan

Professor of Clinical Diabetes and Metabolism, Cardiff University
Verified email at dayan.co.uk
Cited by 21171

Chronic autoimmune thyroiditis

CM Dayan, GH Daniels�- New England journal of medicine, 1996 - Mass Medical Soc
centimeter). When more severe thyroiditis (more than 40 foci per square centimeter) is
considered, the prevalence declines to 5 to 15 percent in women and 1 to 5 percent in men. …

Global epidemiology of hyperthyroidism and hypothyroidism

…, G Gutierrez-Buey, JH Lazarus, CM Dayan…�- Nature Reviews�…, 2018 - nature.com
Thyroid hormones are essential for growth, neuronal development, reproduction and regulation
of energy metabolism. Hypothyroidism and hyperthyroidism are common conditions with …

Determinant spreading and the dynamics of the autoimmune T-cell repertoire

PV Lehmann, EE Sercarz, T Forsthuber, CM Dayan…�- Immunology today, 1993 - cell.com
In this article the authors propose a dynamic model of autoimmunity with T-cell recruitment
and selection leading to changes in the specificity of the anti-self response during the course …

Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes

S Lindley, CM Dayan, A Bishop, BO Roep…�- Diabetes, 2005 - Am Diabetes Assoc
Type 1 diabetes is a T-cell–mediated disease that is associated with loss of immunological
tolerance to self-antigens. The mechanisms involved in maintenance of peripheral tolerance …

[HTML][HTML] Teplizumab and β-cell function in newly diagnosed type 1 diabetes

EL Ramos, CM Dayan, L Chatenoud…�- …�England Journal of�…, 2023 - Mass Medical Soc
Background Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved
by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) …

The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy

…, GJ Kahaly, L Baldeschi, CM Dayan…�- European journal of�…, 2021 - academic.oup.com
Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD).
Choice of treatment should be based on the assessment of clinical activity and severity of GO. …

Psychological well‐being in patients on 'adequate' doses of l‐thyroxine: results of a large, controlled community‐based questionnaire study

…, K Vedhara, R Greenwood, CM Dayan�- Clinical�…, 2002 - Wiley Online Library
objective Over 1% of the UK population is receiving thyroid hormone replacement with l‐thyroxine
(T4). However, many patients complain of persistent lethargy and related symptoms …

[HTML][HTML] Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

…, JM Tremble, AJ Bishop, CM Dayan…�- The Journal of�…, 2004 - Am Soc Clin Investig
According to the quality of response they mediate, autoreactive T cells recognizing islet β
cell peptides could represent both disease effectors in the development of type 1 diabetes (…

[HTML][HTML] CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

…, JS Allen, TIM Tree, M Zhao, CM Dayan…�- The Journal of�…, 2008 - Am Soc Clin Investig
The final pathway of β cell destruction leading to insulin deficiency, hyperglycemia, and
clinical type 1 diabetes is unknown. Here we show that circulating CTLs can kill β cells via …

[HTML][HTML] Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial

…, E Paxton, A Polet, C Thompson, CM Dayan�- The Lancet, 2011 - thelancet.com
Background Lifestyle changes soon after diagnosis might improve outcomes in patients with
type 2 diabetes mellitus, but no large trials have compared interventions. We investigated …